Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

7876 items from SEC EDGAR · filings · clear filters

  • SEC EDGAR•filings
    8-K - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Filer)

    Marsh & McLennan Companies, Inc. filed a Form 8-K on October 15, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - FMC CORP (0000037785) (Filer)

    FMC Corp filed a Form 8-K on October 15, 2026, providing its results of operations and financial condition, along with financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - COMMERCIAL METALS Co (0000022444) (Filer)

    Commercial Metals Co filed a Form 8-K on October 15, 2026, reporting results of operations and financial condition, providing a Regulation FD disclosure, and including financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Ocugen, Inc. (0001372299) (Filer)

    Ocugen, Inc. filed a Form 8-K on October 15, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - SurgePays, Inc. (0001392694) (Filer)

    SurgePays, Inc. filed a Form 8-K with the SEC on October 15, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Bank7 Corp. (0001746129) (Filer)

    Bank7 Corp filed a Form 8-K on October 15, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)

    Jasper Therapeutics, Inc. filed a Form 8-K on October 15, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001213900-26-109587.

  • SEC EDGAR•filings
    8-K - Valion Bio, Inc. (0001787740) (Filer)

    Valion Bio, Inc. filed a Form 8-K on October 15, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - ManpowerGroup Inc. (0000871763) (Filer)

    ManpowerGroup Inc. filed a Form 8-K on October 15, 2026, reporting its results of operations and financial condition (Item 2.02) and providing financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - ALLSTATE CORP (0000899051) (Filer)

    Allstate Corp filed a Form 8-K on October 15, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - ManpowerGroup Inc. (0000871763) (Filer)

    ManpowerGroup filed a Form 8-K on Oct. 15, 2026, reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - FIRST HORIZON CORP (0000036966) (Filer)

    First Horizon Corp filed an 8-K on October 15, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - GIBRALTAR INDUSTRIES, INC. (0000912562) (Filer)

    Gibraltar Industries filed a Form 8-K on October 15, 2026, reporting an entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - PLUG POWER INC (0001093691) (Filer)

    Plug Power Inc. filed a Form 8-K on October 15, 2026, disclosing its results of operations and financial condition and providing accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)

    Aquestive Therapeutics, Inc. filed a Form 8-K on October 15, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Oaktree Acquisition Corp. III Life Sciences (0002029769) (Filer)

    Oaktree Acquisition Corp. III Life Sciences filed a Form 8-K with the SEC on October 15, 2026, providing a Regulation FD Disclosure under Item 7.01.

  • SEC EDGAR•filings
    8-K - KIMBERLY CLARK CORP (0000055785) (Filer)

    Kimberly Clark Corp filed an 8-K on October 15, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - MGP INGREDIENTS INC (0000835011) (Filer)

    MGP Ingredients Inc. filed a Form 8-K on Oct. 15, 2026, reporting amendments to its articles of incorporation/bylaws and a fiscal year change, providing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Krystal Biotech, Inc. (0001711279) (Filer)

    Krystal Biotech, Inc. filed a Form 8-K on October 15, 2026, containing a Regulation FD disclosure (Item 7.01) and financial statements with related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Cronos Group Inc. (0001656472) (Filer)

    Cronos Group Inc. filed a Form 8-K reporting entry into a material definitive agreement, completion of an acquisition or disposition of assets, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - MAYS J W INC (0000054187) (Filer)

    Mays J.W. Inc. filed a Form 8-K reporting the departure and appointment of certain directors and officers and disclosed compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K/A - Esquire Financial Holdings, Inc. (0001531031) (Filer)

    Esquire Financial Holdings, Inc. filed a Form 8-K/A on October 15, 2026, providing its financial statements and related exhibits as required under Item 9.01 of the filing.

  • SEC EDGAR•filings
    8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)

    Tonix Pharmaceuticals Holding Corp. filed a Form 8-K on October 15, 2026 (Accession No. 0001493152-26-047139) reporting Item 2.02 on results of operations and financial condition and Item 8.01 on other events.

  • SEC EDGAR•filings
    8-K - i-80 Gold Corp. (0001853962) (Filer)

    i-80 Gold Corp. filed a Form 8-K on October 15, 2026, providing a Regulation FD disclosure under Item 7.01.

  • SEC EDGAR•filings
    8-K - US BANCORP \DE\ (0000036104) (Filer)

    US Bancorp filed a Form 8-K on October 15, 2026, including its results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - PENSKE AUTOMOTIVE GROUP, INC. (0001019849) (Filer)

    Penske Automotive Group filed a Form 8-K reporting a material definitive agreement, the creation of a direct financial obligation, changes to directors and officer compensation, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Hamilton Lane INC (0001433642) (Filer)

    Hamilton Lane Inc. filed a Form 8-K on October 15, 2026, reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - PENSKE AUTOMOTIVE GROUP, INC. (0001019849) (Filer)

    Penske Automotive Group filed a Form 8-K on October 15, 2026 (Accession No. 0001140361-26-039661), reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - PNC FINANCIAL SERVICES GROUP, INC. (0000713676) (Filer)

    PNC Financial Services Group, Inc. filed a Form 8-K on October 15, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - MongoDB, Inc. (0001441816) (Filer)

    MongoDB, Inc. filed a Form 8-K on October 15, 2026, reporting departures, elections, appointments and related compensation arrangements for certain officers, and included its financial statements and exhibits.